InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR)

Historical Holders from Q2 2021 to Q3 2025

Symbol
NSPR on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
42,079,879
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,730,210
Holdings value
$54,778,990
% of all portfolios
0%
Number of holders
40
Number of buys
24
Number of sells
8
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MARSHALL WACE, LLP 10% $67,729,915 28,103,699 MARSHALL WACE, LLP 30 Sep 2025
Rosalind Advisors, Inc. 9.9% +5.6% $26,698,663 10,987,104 0% Rosalind Advisors, Inc. 01 Aug 2025
Nantahala Capital Management, LLC 10% 0% $10,256,307 +$2,934,884 4,255,729 +40% Nantahala Capital Management, LLC 30 Sep 2025
Lawless Michael A 8.6% $8,711,502 3,614,731 Michael A. Lawless 26 Jun 2025
Aberdeen Group plc 6% $5,979,492 2,481,117 Aberdeen Group plc 01 Oct 2025
Parkman Healthcare Partners LLC 5.8% $5,881,926 2,440,633 Parkman Healthcare Partners LLC 30 Sep 2025
Nantahala Capital Partners Limited Partnership 5.7% $5,827,419 2,418,016 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 30 Sep 2025
Velan Capital Investment Management LP 5.1% $5,209,186 2,143,698 Velan Capital Master Fund LP 30 Jul 2025
ORBIMED ADVISORS LLC 4.1% -44% $5,141,506 2,133,405 0% OrbiMed Advisors LLC 30 Sep 2025
Shore Craig 3.5% $3,577,657 1,484,505 Craig Shore 26 Jun 2025
As of 30 Sep 2025 InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22,730,210 shares of 42,079,879 outstanding shares and own 54% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) own 54% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Rosalind Advisors, Inc. 9.3% 3,905,743 +71% 3.4% $9,412,840
Nantahala Capital Management, LLC 8% 3,376,484 +46% 0.5% $8,137,327
Aberdeen Group plc 5.9% 2,481,117 0.01% $5,979,492
Parkman Healthcare Partners LLC 5.8% 2,440,633 +98% 0.65% $5,881,926
Velan Capital Investment Management LP 5.1% 2,143,698 +137% 4.9% $5,166,312
ORBIMED ADVISORS LLC 5.1% 2,133,405 0% 0.12% $5,141,506
MARSHALL WACE, LLP 4.4% 1,860,405 0% 0% $4,483,576
Soleus Capital Management, L.P. 3.5% 1,470,934 -22% 0.19% $3,544,951
Ghisallo Capital Management LLC 2.2% 921,587 0.07% $2,221,025
PURA VIDA INVESTMENTS, LLC 1.1% 450,517 0% 7% $1,085,746
Huntleigh Advisors, Inc. 0.63% 264,004 +113% 0.11% $636,250
Affiance Financial, LLC 0.59% 250,370 +32% 0.11% $603,392
INGALLS & SNYDER LLC 0.53% 225,002 0.02% $542,000
MILLENNIUM MANAGEMENT LLC 0.35% 147,423 +766% 0% $355,289
Schonfeld Strategic Advisors LLC 0.2% 86,092 +130% 0% $207,480
MORGAN STANLEY 0.2% 86,011 -8.6% 0% $207,286
IRONWOOD INVESTMENT MANAGEMENT LLC 0.15% 61,579 +1.7% 0.06% $148,405
COURIER CAPITAL LLC 0.13% 55,000 +83% 0.01% $132,550
BlackRock, Inc. 0.13% 53,714 +47% 0% $129,451
VESTIA PERSONAL WEALTH ADVISORS 0.1% 42,425 +136% 0.06% $102,244
CITADEL ADVISORS LLC 0.09% 37,954 +45% 0% $91,469
NORTHERN TRUST CORP 0.08% 33,572 -26% 0% $80,909
COMMONWEALTH EQUITY SERVICES, LLC 0.08% 32,550 0% $78,000
Mesirow Financial Investment Management, Inc. 0.07% 30,000 0% 0% $72,300
Uniting Wealth Partners, LLC 0.05% 21,066 0.01% $50,769

Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 22,730,210 $54,778,990 +$20,913,742 $2.41 40
2025 Q2 14,061,920 $31,922,818 +$2,512,314 $2.27 36
2025 Q1 12,917,013 $34,746,467 +$554,607 $2.69 34
2024 Q4 12,710,904 $33,407,511 +$811,860 $2.63 29
2024 Q3 12,402,374 $33,215,449 +$1,209,473 $2.68 27
2024 Q2 11,951,922 $29,859,952 +$4,430,429 $2.50 23
2024 Q1 10,178,288 $23,962,111 -$399,401 $2.37 26
2023 Q4 10,339,444 $29,052,785 +$1,669,140 $2.81 27
2023 Q3 8,762,225 $28,673,807 +$2,327,230 $3.27 24
2023 Q2 8,054,236 $20,216,372 +$20,007,580 $2.51 21
2023 Q1 89,904 $100,616 -$54,293 $1.11 12
2022 Q4 155,792 $132,918 +$21,576 $0.8595 13
2022 Q3 112,317 $165,630 -$78,516 $1.49 10
2022 Q2 129,060 $256,202 -$9,358 $1.99 10
2022 Q1 140,048 $449,524 -$93,944 $3.21 11
2021 Q4 172,274 $520,325 -$26,854 $3.01 14
2021 Q3 170,103 $703,514 -$1,360,151 $4.10 13
2021 Q2 450,832 $2,277,560 +$2,277,558 $5.05 14